TABLE 1. GLOBAL ORPHAN DRUGS MARKET, BY DISEASE TYPE, 2014-2022 ($MILLION)
TABLE 2. KEY ORPHAN THERAPEUTIC DRUGS FOR RARE FORMS OF ONCOLOGIC DISEASES
TABLE 3. ONCOLOGIC DISEASE ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 4. KEY ORPHAN THERAPEUTIC DRUGS FOR RARE FORMS OF METABOLIC DISEASES
TABLE 5. METABOLIC DISEASE ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 6. KEY ORPHAN THERAPEUTIC DRUGS FOR RARE FORMS OF HEMATOLOGIC AND IMMUNOLOGIC DISEASES
TABLE 7. HEMATOLOGIC AND IMMUNOLOGIC DISEASE ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 8. KEY ORPHAN THERAPEUTIC DRUGS FOR RARE FORMS OF INFECTIOUS DISEASES
TABLE 9. INFECTIOUS DISEASE ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 10. KEY ORPHAN THERAPEUTIC DRUGS FOR RARE FORMS OF NEUROLOGIC DISEASES
TABLE 11. NEUROLOGIC DISEASE ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 12. OTHER RARE DISEASES ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 13. GLOBAL ORPHAN DRUGS MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 14. NON-HODGKIN'S LYMPHOMA ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 15. ACUTE MYELOID LEUKEMIA ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16. CYSTIC FIBROSIS ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 17. GLIOMA ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 18. PANCREATIC CANCER ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 19. OVARIAN CANCER ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20. MULTIPLE MYELOMA ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 21. DUCHENNE MUSCULAR DYSTROPHY ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 22. GRAFT VS. HOST DISEASE ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 23. RENAL CELL CARCINOMA ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 24. OTHER INDICATIONS ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 25. ORPHAN DRUGS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 26. NORTH AMERICA ORPHAN DRUGS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 27. NORTH AMERICA ORPHAN DRUGS MARKET, BY DISEASE TYPE, 2014-2022 ($MILLION)
TABLE 28. NORTH AMERICA ORPHAN DRUGS MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 29. EUROPE ORPHAN DRUGS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 30. EUROPE ORPHAN DRUGS MARKET, BY DISEASE TYPE, 2014-2022 ($MILLION)
TABLE 31. EUROPE ORPHAN DRUGS MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 32. ASIA-PACIFIC ORPHAN DRUGS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 33. ASIA-PACIFIC ORPHAN DRUGS MARKET, BY DISEASE TYPE, 2014-2022 ($MILLION)
TABLE 34. ASIA-PACIFIC ORPHAN DRUGS MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 35. LAMEA ORPHAN DRUGS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 36. LAMEA ORPHAN DRUGS MARKET, BY DISEASE TYPE, 2014-2022 ($MILLION)
TABLE 37. LAMEA ORPHAN DRUGS MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 38. ABBVIE: COMPANY SNAPSHOT
TABLE 39. ABBVIE: OPERATING SEGMENTS
TABLE 40. ABBVIE: OPERATING SEGMENTS
TABLE 41. AEGERION PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 42. AEGERION PHARMACEUTICALS: OPERATING SEGMENTS
TABLE 43. AEGERION PHARMACEUTICALS: OPERATING SEGMENTS
TABLE 44. BRISTOL-MYERS SQUIBB: COMPANY SNAPSHOT
TABLE 45. BRISTOL-MYERS SQUIBB: OPERATING SEGMENTS
TABLE 46. BRISTOL-MYERS SQUIBB: PRODUCT PORTFOLIO
TABLE 47. CELGENE: COMPANY SNAPSHOT
TABLE 48. CELGENE: OPERATING SEGMENTS
TABLE 49. CELGENE: PRODUCT PORTFOLIO
TABLE 50. ROCHE: COMPANY SNAPSHOT
TABLE 51. ROCHE: OPERATING SEGMENT
TABLE 52. ROCHE: PRODUCT PORTFOLIO
TABLE 53. GSK: COMPANY SNAPSHOT
TABLE 54. GSK: OPERATING SEGMENTS
TABLE 55. GSK: PRODUCT PORTFOLIO
TABLE 56. J&J: COMPANY SNAPSHOT
TABLE 57. J&J: OPERATING SEGMENTS
TABLE 58. J&J: PRODUCT PORTFOLIO
TABLE 59. NOVARTIS: COMPANY SNAPSHOT
TABLE 60. NOVARTIS: OPERATING SEGMENTS
TABLE 61. NOVARTIS: PRODUCT PORTFOLIO
TABLE 62. PFIZER: COMPANY SNAPSHOT
TABLE 63. PFIZER: OPERATING SEGMENTS
TABLE 64. PFIZER: PRODUCT CATEGORY
TABLE 65. SANOFI: COMPANY SNAPSHOT
TABLE 66. SANOFI: OPERATING SEGMENTS
TABLE 67. SANOFI: PRODUCT PORTFOLIO

LIST OF FIGURE

FIGURE 1. SEGMENTATION SNAPSHOT: GLOBAL ORPHAN DRUGS MARKET, 2014-2022
FIGURE 2. GEOGRAPHY SNAPSHOT: GLOBAL ORPHAN DRUGS MARKET, 2014-2022
FIGURE 3. ORPHAN DRUGS MARKET: SEGMENTATION
FIGURE 4. TOP INVESTMENT POCKETS IN GLOBAL ORPHAN DRUGS MARKET
FIGURE 5. TOP WINNING STRATEGIES: TYPE AND COMPANY
FIGURE 6. TOP WINNING STRATEGIES: TYPE AND NATURE
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. PATENT REGISTERED/APPROVED- BY YEAR
FIGURE 13. PATENT REGISTERED/APPROVED- BY REGION
FIGURE 14. PATENT REGISTERED/APPROVED- BY INDICATION
FIGURE 15. RESTRAINTS AND DRIVERS: GLOBAL ORPHAN DRUGS MARKET
FIGURE 16. COSTS PER YEAR ASSOCIATED WITH MOST EXPENSIVE ORPHAN DRUGS
FIGURE 17. ORPHAN DRUGS MARKET: DISEASE TYPE SEGMENTATION
FIGURE 18. CANCER: NUMBER OF DEATHS (UNIT) IN U.S., 2017 ESTIMATES
FIGURE 19. GLOBAL ORPHAN DRUGS MARKET:DISEASE CONDITION SEGMENTATION
FIGURE 20. U.S. ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 21. CANADA ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 22. MEXICO ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 23. GERMANY ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 24. UK ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 25. FRANCE ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 26. ITALY ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 27. SPAIN ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 28. REST OF EUROPE ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 29. JAPAN ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 30. CHINA ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 31. INDIA ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 32. AUSTRALIA ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 33. SOUTH KOREA ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 34. TAIWAN ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 35. REST OF ASIA-PACIFIC ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 36. BRAZIL ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 37. TURKEY ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 38. SAUDI ARABIA ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 39. SOUTH AFRICA ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 40. REST OF LAMEA ORPHAN DRUGS MARKET, 2014-2022 ($MILLION)
FIGURE 41. ABBVIE: REVENUE, 20142016 ($MILLION)
FIGURE 42. ABBVIE: REVENUE BY PRODUCT, 2016 (%)
FIGURE 43. ABBVIE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 44. AEGERION PHARMACEUTICALS: REVENUE, 20132015 ($MILLION)
FIGURE 45. AEGERION PHARMACEUTICALS: REVENUE BY PRODUCT, 2015 (%)
FIGURE 46. AEGERION PHARMACEUTICALS: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 47. BRISTOL-MYERS SQUIBB: REVENUE, 20142016 ($MILLION)
FIGURE 48. BRISTOL-MYERS SQUIBB: REVENUE BY PRODUCTS, 2016 (%)
FIGURE 49. BRISTOL-MYERS SQUIBB: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 50. CELGENE: REVENUE, 20142016 ($MILLION)
FIGURE 51. CELGENE: REVENUE BY PRODUCTS, 2016 (%)
FIGURE 52. CELGENE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 53. ROCHE: REVENUE, 20142016 ($MILLION)
FIGURE 54. ROCHE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 55. ROCHE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 56. GSK: REVENUE, 20142016 ($MILLION)
FIGURE 57. GSK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 58. GSK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 59. J&J: REVENUE, 20142016 ($MILLION)
FIGURE 60. J&J: REVENUE BY SEGMENT, 2016 (%)
FIGURE 61. J&J: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 62. NOVARTIS: REVENUE, 20142016 ($MILLION)
FIGURE 63. NOVARTIS: REVENUE BY SEGMENT, 2016 ($MILLION)
FIGURE 64. NOVARTIS: REVENUE BY GEOGRAPHY, 2016 ($MILLION)
FIGURE 65. PFIZER: REVENUE, 20142016 ($MILLION)
FIGURE 66. PFIZER: REVENUE BY SEGMENT, 2016 ($MILLION)
FIGURE 67. PFIZER: REVENUE BY GEOGRAPHY, 2016 ($MILLION)
FIGURE 68. SANOFI: REVENUE, 20142016 ($MILLION)
FIGURE 69. SANOFI: REVENUE BY SEGMENT, 2016 ($MILLION)
FIGURE 70. SANOFI: REVENUE BY GEOGRAPHY, 2016 ($MILLION)